Symptoms and How ASMD Affects the Body

Chronic Visceral ASMD affects multiple systems in the body because the enzyme deficiency occurs in many different tissues ^[1]. While the experience of the disease is highly heterogeneous—meaning it varies widely from person to person—certain hallmark symptoms and organ involvements are common across the spectrum ^[2][3].

The Hallmark: Enlarged Organs

The most frequent sign of Chronic Visceral ASMD is the enlargement of the internal organs, particularly the spleen and the liver.

• Splenomegaly (Enlarged Spleen): This is often the first symptom noticed, appearing in nearly all patients at the time of diagnosis ^[3][2]. The spleen can grow to be 4 to 29 times its normal size ^[3]. This enlargement can cause a visible bulge in the abdomen, a feeling of “fullness,” early satiety (feeling full quickly when eating), or physical discomfort.
• Hepatomegaly (Enlarged Liver): An enlarged liver is also common, occurring in about 50% to 88% of patients ^[2][3]. While the liver enlargement itself may not cause pain, it can lead to complications over time, such as liver scarring (fibrosis). In uncommon, severe cases, this can progress to liver failure, though organ enlargement alone does not mean advanced liver disease is present ^[4][5].

Respiratory Impact: Lung Health

Pulmonary (lung) involvement is a major feature of the disease and often worsens gradually over time ^[3].

• Interstitial Lung Disease (ILD): This is a term for a group of conditions that cause scarring or inflammation of the lung tissue ^[6]. In ASMD, fat-filled cells accumulate in the walls of the small air sacs in the lungs, making them stiff ^[5].
• Reduced DLCO: Doctors use a test called DLCO (Diffusing Capacity of the Lungs for Carbon Monoxide) to measure how well oxygen moves from the lungs into the blood. In many patients, this capacity is reduced, which can lead to shortness of breath during exercise (exertional dyspnea) or, eventually, even at rest ^[6][3].

Blood and Lipid Abnormalities

The accumulation of sphingomyelin also disrupts the normal balance of fats and blood cells in the body.

• Thrombocytopenia (Low Platelets): Because the enlarged spleen “traps” blood cells, many patients have a low number of platelets ^[7][2]. Platelets are essential for clotting; a low count can lead to easy bruising, frequent nosebleeds, or prolonged bleeding from small cuts.
• Atherogenic Dyslipidemia: Most patients have abnormal levels of fats in the blood, notably very low levels of HDL cholesterol (the “good” cholesterol) and elevated LDL ^[2]. While this profile is considered “atherogenic,” your actual cardiovascular risk is assessed using ordinary factors like blood pressure, smoking, and family history, rather than assuming heart disease is an established outcome of ASMD alone ^[8].

Growth and Bone Health

In children and adolescents, ASMD can impact physical development and the skeletal system.

• Growth Impairment: Children with ASMD often experience delays in growth and may be shorter than their peers ^[3]. These growth deficits frequently persist into adulthood, especially in those with more significant spleen enlargement ^[8].
• Osteopenia and Bone Issues: Many patients have osteopenia, a condition where bone mineral density is lower than normal ^[9]. This can make bones more fragile and increase the risk of fractures or bone pain.

Symptoms vs. Clinical Findings

Daily Life and Progression

It is important to remember that symptoms do not progress at the same rate for everyone. In some adults, symptoms may remain stable for many years, while in others—particularly those diagnosed in early childhood—manifestations may worsen more steadily ^[2][3]. Fatigue and early fullness can significantly impact your daily quality of life, school, or work. Regular monitoring of these systems is the key to managing the disease effectively.